Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC

Clinical trial NCT07639138 · RECRUITING

Trial details

NCT number: NCT07639138
Sponsor: Shunda Du
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)

Start date: 2026-06-10
Primary completion: 2028-06-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.